Jeffrey Kent, MD, FACG, FACP
Chief Medical Officer
Dr. Kent brings to Sling over two decades of life sciences experience in clinical development, medical affairs and medical/commercial strategy, including rare diseases, and expertise in multiple product launches including CELEBREX, HUMIRA, KRYSTEXXA, and TEPEZZA. Most recently he served as Executive Vice President, Medical Affairs and Outcomes Research at Horizon Therapeutics. Dr. Kent has had the opportunity to support multiple New Drug Applications, Biologics License Applications, U.S. Food & Drug Administration Advisory Committee Meetings, and product launches around the world.
Dr. Kent earned a BA in economics from Franklin and Marshall College and his Doctor of Medicine from Jefferson Medical College.